Ubidecarenone and toxic cardiopathy from antiblastic therapy with daunoblastine
Luccarelli, G.; Angelucci, E.; Giardini, C.; Nicolini, G.; Baronciani, D.
Bollettino Chimico Farmaceutico 125(3): 34s-39s
1986
ISSN/ISBN: 0006-6648 PMID: 3741652 Document Number: 276928
Document emailed within 1 workday
Related Documents
Masini, V. 1986: The heart in radiation and cytostatic antiblastic therapy Cardiologia 31(5): 345-349Croce, G.; Frenguelli, A. 1970: Antiblastic therapy, using intra-arterial infusions. Observations on 10 cases Bollettino Delle Malattie Dell'orecchio Della Gola del Naso 88(4): 261-269
Cappellano, R.S. 1974: Intra-arterial antiblastic drug therapy in intracranial metastatic tumors Amb: Revista da Associacao Medica Brasileira 20(12): 450-452
Dragagna, G.; Saponaro, A.; Paravati, V.; Amici, A.; Ciuffetta, D.; Sucamele, D.; Paris, A.; Martelli, M. 1988: Early use of ubidecarenone in patients with cardiopathies without signs of decompensation. Metabolic and polygraphic evaluation Minerva Cardioangiologica 36(6): 311-317
Saitta, A.; Castaldo, M.; Sardo, A.; Cinquegrani, M.; Bonaiuto, M.; Zema, M.; Gravina, M.; Mangano, C. 1999: Elevated levels of lipoprotein(a) are present in subjects with early ischemic cardiopathy and with a familial history of ischemic cardiopathy Minerva Medica 90(5-6): 151-158
Bresolin, N.; Bet, L.; Ferrante, C.; Binda, A.; Carenzi, A.; Moggio, M.; Comi, G.; Scarlato, G. 1988: Immunological and biochemical studies and pilot therapeutic trial with ubidecarenone in Kearns-Sayre patients Advances in Neurology 48: 239-256
Fox, K.M.; Quyyumi, A.; Wright, C. 1983: The medical treatment of angina. Therapy planning based on the pathogenesis of the ischemic cardiopathy Recenti Progressi in Medicina 74(9): 1039-1052
Cifuentes de Castro, L. 1970: Preliminary tests using a new antiblastic of vegetable origin Revista Clinica Espanola 118(3): 219-224
Rigano, A.; Adamo, V.; Altavilla, G.; d'Aquino, S. 1989: Antiblastic treatment of advanced cervical carcinoma and its recurrences: assessment of four different polychemotherapies used for a decade European Journal of Gynaecological Oncology 10(4): 271-276
Micu, D.; Gociu, M.; Zamfirescu-gheorghiu, M.; Mihăilescu, E.; Cheţa, D.; Cheţa, N.; Astaldi, A. 1975: Cytoenzymochemical effects of some antiblastic drugs and prediction of response to chemotherapy in acute leukemias Medecine Interne 13(3): 199-203
Ghinelli, C.; Pons, M.L.; Terzano, G. 1975: Cytologic changes in Erlich ascites tumor treated with antiblastic drugs and hyperbaric oxygen Acta Cytologica 19(1): 43-44
Galletti, F.; Sturniolo, M.G. 1982: Neurological problems in malignant hemopathies in children. II. Neurotoxicity of antiblastic drugs and radiotherapy Minerva Pediatrica 34(11): 485-491
Falke, K.J. 1995: The therapy of toxic pulmonary edema Deutsche Medizinische Wochenschrift 120(51-52): 1801
Bacci, G.; Pagani, P.A. 1975: Supplementary antiblastic polychemotherapy in localized malignant bone tumors. I. Ewing's sarcoma and osteosarcoma La Chirurgia Degli Organi di Movimento 62(5): 491-506
Valero, J.; Vázquez-Barro, A.; Sáez, E.; López-Suso, E.; Martelo, F. 1997: Toxic epidermal necrolysis and corticosteroid therapy Anales de Medicina Interna 14(12): 650-651
Novelli, F.; Allione, A.; Bernabei, P.; Rigamonti, L.; Forni, G. 1997: Antiblastic chemotherapy drugs up-modulate interferon-gamma receptor expression on human malignant T cells Cancer Detection and Prevention 21(2): 191-195
Moskaliuk, M.P.; Silina, L.V. 1987: Hemosorption in the combined therapy of infectious toxic shock Anesteziologiia i Reanimatologiia 2: 53-54
Mantsurov, N.E. 1982: Effect of preparations increasing the antiblastic action of antitumor substances on the results of postoperative chemotherapy in lung cancer Vrachebnoe Delo 4: 88-91
Schicha, H.; Dietlein, M. 2002: Graves' disease nd toxic nodular goiter--radioiodine therapy NUKLEARMEDIZIN. Nuclear Medicine 41(2): 63-70
Beszterczey, A.; Pecknold, J.C. 1971: Toxic psychosis induced by high-dosage chlorpromazine therapy Canadian Medical Association Journal 104(10): 884 Passim